Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
0.97005
-0.0400 (-3.96%)
At close: Sep 28, 2026, 4:00 PM EDT
0.9201
-0.0499 (-5.15%)
After-hours: Sep 28, 2026, 4:10 PM EDT
Pluri Employees
As of June 30, 2026, Pluri had 113 total employees, including 92 full-time and 21 part-time employees. The number of employees decreased by 29 or -20.42% compared to the previous year.
Employees
113
Change (1Y)
-29
Growth (1Y)
-20.42%
Revenue / Employee
$8,991
Profits / Employee
-$210,805
Market Cap
11.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 113 | -29 | -20.42% | 92 | 21 |
| Jun 30, 2025 | 142 | 24 | 20.34% | 127 | 15 |
| Jun 30, 2024 | 118 | -16 | -11.94% | 106 | 12 |
| Jun 30, 2023 | 134 | -25 | -15.72% | 123 | 11 |
| Jun 30, 2022 | 159 | -3 | -1.85% | 154 | 5 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| IN8bio | 18 |
| Lantern Pharma | 16 |
| AEON Biopharma | 8 |
| Intensity Therapeutics | 7 |
| Tempest Therapeutics | 4 |
PLUR News
- 17 days ago - Pluri files $200M mixed securities shelf - TheFly
- 4 weeks ago - Pluri prices 2.23M shares at $1.50 in registered direct offering - TheFly
- 4 weeks ago - Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - GlobeNewsWire
- 6 weeks ago - Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewsWire
- 2 months ago - Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK - GlobeNewsWire
- 2 months ago - Pluri announces chairman Alejandro Weinstein ownership surpasses 30% - TheFly
- 3 months ago - Plurilock Announces Results of Annual General Meeting - Newsfile Corp
- 3 months ago - Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing - GlobeNewsWire